The role of azurocidin in patients with familial Mediterranean fever and AA amyloidosis and its association with cardiovascular risk factors

被引：0
|
作者：
Ilter Bozaci
Erhan Tatar
机构：
[1] University of Health Sciences Bozyaka Training and Research Hospital,Department of Nephrology
来源：
International Urology and Nephrology | 2021年 / 53卷
关键词：
Azurocidin; FMF; AA amyloidosis; Inflammation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：531 / 538
页数：7
相关论文
共 50 条
  • [1] The role of azurocidin in patients with familial Mediterranean fever and AA amyloidosis and its association with cardiovascular risk factors
    Bozaci, Ilter
    Tatar, Erhan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (03) : 531 - 538
  • [2] Predicting genetic risk factors for AA amyloidosis in Algerian patients with familial Mediterranean fever
    Djouher Ait-Idir
    Bahia Djerdjouri
    Khaled Latreche
    Rawda Sari-Hamidou
    Ghalia Khellaf
    Molecular Genetics and Genomics, 2024, 299
  • [3] Predicting genetic risk factors for AA amyloidosis in Algerian patients with familial Mediterranean fever
    Ait-Idir, Djouher
    Djerdjouri, Bahia
    Latreche, Khaled
    Sari-Hamidou, Rawda
    Khellaf, Ghalia
    MOLECULAR GENETICS AND GENOMICS, 2024, 299 (01)
  • [4] Identification of factors for persistence of AA amyloidosis in patients with Familial Mediterranean Fever
    Terre, Alexandre
    Savey, Lea
    Buob, David
    Grateau, Gilles
    Georgin-Lavialle, Sophie
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 108 : 128 - 130
  • [5] AA-AMYLOIDOSIS RISK FACTORS IN PATIENTS WITH DIFFERENT GENETIC VARIANTS OF FAMILIAL MEDITERRANEAN FEVER
    Bogdanova, Marina
    Rameev, Vilen Vilevich
    Simonyan, Armine Hachaturovna
    Kozlovskaya, Lidia Vladimirovna
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 115 - 115
  • [6] Predictors of AA amyloidosis in familial Mediterranean fever
    Mukhin, Nikolay A.
    Kozlovskaya, Lidiya V.
    Bogdanova, Marina V.
    Rameev, Vilen V.
    Moiseev, Sergey V.
    Simonyan, Armine Kh.
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (07) : 1257 - 1261
  • [7] Predictors of AA amyloidosis in familial Mediterranean fever
    Nikolay A. Mukhin
    Lidiya V. Kozlovskaya
    Marina V. Bogdanova
    Vilen V. Rameev
    Sergey V. Moiseev
    Armine Kh. Simonyan
    Rheumatology International, 2015, 35 : 1257 - 1261
  • [8] CARDIOVASCULAR DISEASE RISK ASSESSMENT IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER RELATED AMYLOIDOSIS
    Romano, M.
    Yilmaz, M.
    Jackson, B.
    Acikel, C.
    Piskin, D.
    Berard, R.
    Demirkaya, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 845 - 845
  • [9] TOCILIZUMAB (TCZ) IN THE TREATMENT OF AA AMYLOIDOSIS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER
    Ozdogan, H.
    Ugurlu, S.
    Hacioglu, A.
    Adibnia, Y.
    Hamuryudan, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 313 - 313
  • [10] Tocilizumab in the treatment of patients with AA amyloidosis secondary to familial Mediterranean fever
    Yilmaz, Sedat
    Cinar, Muhammet
    Simsek, Ismail
    Erdem, Hakan
    Pay, Salih
    RHEUMATOLOGY, 2015, 54 (03) : 564 - 565
12345